Drug Law Weekly

Cordis Corp. - Data supports performance of CYPHER Sirolimus-eluting Coronary Stent

Corixa Corp. - Immunotherapeutics firm reports quarterly loss of $0.31 per share

Cuban Center for Genetic Engineering & Biotech - Hepatitis C DNA vaccine induces strong DTH response in mice

CytoGenix, Inc. - Results of anti-sepsis preclinical animal trials released

Daiichi Pharmaceutical Corp. - FDA approves once-daily Floxin Otic (ofloxacin otic solution)

DePuy Spine - Minimally invasive lumbar fusion procedure offers escape from pain

Delex Therapeutics - First patients dosed in phase II AeroLEF trial for post-surgical pain

Dialysis - Regency Hospital of Odessa announces new services

Drug Abuse - U.S. drug czar wants to reduce drug supply, abuse

Duke University - Aggressive heart drugs still underused, despite blood chemical status

Elite Pharmaceuticals, Inc. - Manufacture of validation batches for allergy drug completed

Food Allergies - Senate passes Food Allergen Labeling and Consumer Protection Act

GTC Biotherapeutics, Inc. - Company reports net losses largely due to ATryn submission

Genome Therapeutics Corp. - Factive receives marketing approval in Canada, ready for U.S. launch

Genzyme Corp., Framingham - Vectors harboring liver-restricted promoter yield long term gene expression

German Federal Research Center for Nutrition - Pressure treatment reduces infectivity of prions

GlaxoSmithKline - Lamivudine helps keep HBV at bay during cancer chemotherapy

GlaxoSmithKline KK - Novel benzophenones show promise as anti-HIV NNRTIs

Guidant Corp. - Stent trials demonstrate positive outcomes in high-risk patients

Hepatitis C Virus - New York's refusal to treat hepatitis C patients continues to draw criticism

Human Genome Sciences, Inc. - ABthrax found to be safe and well tolerated

IMPAX Laboratories, Inc. - FDA gives tentative approval for generic version of Tricor tablets

Inhibitex, Inc. - Company initiates enrollment in phase II trial for Aurexis

Inst. for Clinical & Exp. Med., Prague - Effect of CyA on big ET-1 levels 1 year after OHTx characterized

Inst. of Bioeng. & Nanotechnology, Singapore - Chimeric peptides look promising for delivering genes to select neurons

Institute for Genomic Research - "Male-targeting" bacterium's genome is deciphered

Ipsogen - Diagnostic tool enables analysis of molecular characteristics of breast tumors

Johannes-Gutenberg-Universitat - Therapeutic options for diabetes-related bladder dysfunction outlined

Johns Hopkins University - Combo of two natural toxins may be novel treatment for blood cancer

Pall Corporation - New protein purification process eliminates need for DNA testing

St. Jude Children's Hospital - Influenza A viruses obtained from Vero cells by reverse genetics

U.S. Food & Drug Administration - Method to determine atropine sulfate in commercial products developed

U.S. Food and Drug Administration - FDA and EPA announce the revised consumer advisory on methylmercury in fish

World Health Organization - World health experts warn that major flu outbreak overdue

Wright Medical Group, Inc. - Allomatrix Injectable Putty receives FDA clearance